A multidisciplinary renal clinic for corticosteroid-induced bone disease

Pharmacotherapy

Volumn 20, Issue 2, 2000, Pages 206-216

  Joy, Melanie S ^a,b   Neyhart, Clara D ^a   Dooley, Mary Anne ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCITONIN; CALCITRIOL; CALCIUM; CONJUGATED ESTROGEN; CORTICOSTEROID; ERGOCALCIFEROL; ESTRADIOL; ETIDRONIC ACID; GESTAGEN; HYDROCHLOROTHIAZIDE; PAMIDRONIC ACID; PARATHYROID HORMONE; TESTOSTERONE; VITAMIN D;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CALCIUM DEFICIENCY; CHRONIC GLOMERULONEPHRITIS; CORTICOSTEROID THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HORMONE SUBSTITUTION; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NURSE; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHARMACIST; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; RISK FACTOR; SMOKING; TEAMWORK; VITAMIN BLOOD LEVEL;

EID: 0033977533     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.3.206.34787     Document Type: Article

References (39)

1. Brainsky A, Glick H, Lydick E, et al. The economic cost of hip fractures in community-dwelling older adults: a prospective study. J Am Geriatr Soc 1997;45:281-7.
2. Luckert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112: 352-64.
3. American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996;39(11):1791-1801.
4. Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Bone loss in adults receiving alternate day glucocorticoid therapy: a comparison with daily therapy. Arthritis Rheum 1981;24: 892-8.
5. Boyd G. Effect of inhaled corticosteroids on bone. Respir Med 1994;88(suppl A):45-54.
6. Cvetkovic M, Mann GN, Romero DF, et al. The deleterious effects of long-term cyclosporin A, cyclosporin G, and FK506 on bone mineral metabolism in vivo. Transplantation 1994;57:1231-7.
7. Pichette V, Bonnardeaux A, Prudhomme L, Gagne M, Cardinal J, Ouimet D. Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. Am J Kidney Dis 1996;28(1):105-14.
8. Grotz WH, Mundinger FA, Gugel B, Exner V, Kirste G, Schoolmeyer P. Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients. Transplantation 1994;58:912-15.
9. Sambrook P, Birmingham J, Kelly P, et al. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 1993;328:1747-52.
10. Lukert BP, Johnson BE, Robinson RG Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss J Bone Miner Res 1992;7(9):1063-9.
11. Lindsay R, Tohme JF. Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol 1990;76:290-5.
12. Lufkin EG, Riggs BL. Three-year follow-up on effects of transdermal estrogen. Ann Intern Med 1996;125:77.
13. Reid IR, Wattie DJ, Evans RC, Stapleton JP. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 1996;156:1173-7.
14. Luengo M, Pons F, Martinez de Osaba MJ, Picado C. Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study. Thorax 1994;49:1099-1102.
15. Saag KG, Emkey R, Schnitzner TJ, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 1999;339:292-9.
16. Adachi JD, Bensen WG, Brown J, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997;337:382-7.
17. Cauley JA, Cummings SR, Seeley DG, et al. Effects of thiazide diuretic therapy on bone mass, fracture, and falls: the study of osteoporotic fractures research group. Ann Intern Med 1993;118:666-73.
18. O'Connell MB, Bauwens SF Osteoporosis and osteomalacia In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: a pathophysiologic approach, 3rd ed. Stamford, CT: Appleton & Lange, 1997:1689-1716.
19. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983;309:265-8.
20. Dempster DW, Arlot MA, Meunier PI. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 1983;35:410-17.
21. Julian B, Laskow D, Dubovsky J, Dubovsky E, Curtis J, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991;325:543-50.
22. Klein RG, Arnaud SB, Gallagher JC, Deluca JF, Riggs BL. Intestinal calcium absorption in exogenous hypercortisolism: role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest 1977;60:253-9.
23. Godschalk M, Levy JR, Downs RW. Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells. J Bone Miner Res 1992;7:21-7.
24. Suzuki Y, Ichikawa Y, Saito E, Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 1983;32:151-6.
25. MacAdams MR, White RH, Chipps BE. Reduction in serum testosterone levels during chronic glucocorticoid therapy Ann Intern Med 1986;104:648-51.
26. Hseuh Aj, Erickson GF. Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells. Steroids 1978;32:639-48.
27. Chyun YS, Raisz LF. Opposing effects of prostaglandin-E2 and cortisol in bone growth in organ culture. Clin Res 1982;30: 387A.
28. McCarthy TL, Centrella M, Canalis E. Cortisol inhibits the synthesis of insulin-like growth factor-1 in skeletal cells. Endocrinology 1990;126:1569-75.
29. Kelso A, Munck A. Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones. J Immunol 1984;133:784-91.
30. Centrella M, McCarthy TL, Canalis E. Glucocorticoid control of transforming growth factor beta activity and binding and effects in osteoblast-enriched cultures from fetal rat bone. Mol Cell Biol 1991;11:4490-6.
31. Aroldi A, Tarantino A, Montagnino G, Cesana B, Cocucci C, Ponticelli CL. Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients. Transplantation 1997;63:380-6.
32. Horber FF, Casez JP, Steiger U, Czerniak A, Montandon A, Jaeger P. Changes in bone mass early after kidney transplantation. J Bone Miner Res 1994;9:1-9.
33. Lamy O, Krieg MA, Bigler JM, Burckhardt P, Thiebaud D. Intravenous pamidronate (APD) prevents corticosteroid induced bone loss: a prospective controlled study. Calcif Tissue Int 1994;54:351.
34. Mulder H, Struy A. Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. Br J Rheumatol 1994;33:348-50.
35. Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat JM, Setoain J. Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. Am Rev Respir Dis 1990;142:104-7.
36. Adachi JD, Bensen WG, Bell MJ, et al. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis. Br J Rheumatol 1997;36:255-9.
37. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996;125:961-8.
38. Eastman P. Scientists finding new ways to prevent, fight osteoporosis. AARP Bull 1997;38:1-9.
39. Braith RW, Mills RM, Welsch MA, Keller JW, Pollock ML. Resistance exercise training restores bone mineral density in heart transplant recipients. J Am Coll Cardiol 1996;28(6):1471-7.